Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Germaine™ Laboratories Healgen™ COVID-19/Flu A and B Ag Combo Rapid Test Cassette Box

Catalog No. 23900207
Click to view available options
:

Lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigens. Box of 25 test cassettes.

Lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 by their healthcare provider within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. Positive results do not rule out bacterial infection or co-infection with other viruses.

Detect Three Respiratory Viruses Simultaneously from a Single Sample: Faster diagnosis for improved patient care and cost-effectiveness

  • Rapid Detection: Results available in 15 minutes
  • Excellent Test Performance (comparator method RT-PCR)
  • Simple and Effective: CLIA Waived testing at the point-of-care for use with minimally trained healthcare professionals
  • External Quality Controls Available: Facilitates routine quality procedures
  • Shelf Life that Spans Viral Seasonality: 16 months from date of manufacture at room temperature storage

Box of 25 test cassettes

Specifications

CE Marker

No

Clia Complexity

Waived (EUA)

Detectable Analytes

Influenza A and Influenza B Nucleoprotein Antigens, SARS-CoV-2 Nucleocapsid Antigen

Detection Method

Qualitative Detection

DoA Calibrators

No

Format

Test Cassette

Sample Type

Single Nasal Swab Sample

Sensitivity

Test: SARS-CoV-2 Positive Percent Agreement: 90.2% Negative Percent Agreement: 99.1% Test: Flu A Positive Percent Agreement: 90.0% Negative Percent Agreement: 99.9% Test: Flu B Positive Percent Agreement: 91.2% Negative Percent Agreement: 100.0%

Type

Rapid Test

Disposable

Single-use

For Use With (Application)

Covid and Flu A+B Rapid Test

Form

Swab

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.